8-K current report · filed Oct 22, 2026

Quest Diagnostics (DGX) 8-K Current Report: October 22, 2026

Item 2.02Item EX-99.1DGX overview

Short answer

Quest Diagnostics (DGX) filed an 8-K current report with the SEC on October 22, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Third-quarter 2026 results for period ended September 30, 2026.

Quest Diagnostics 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Third-quarter 2026 results for period ended September 30, 2026
  • Press release issued October 22, 2026
  • Exhibit 99.1 contains financial results and management commentary

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $3.097B, up 10.0%, with requisition volume up 14.5% offset by revenue per requisition down 4.2%
  • Reported diluted EPS $2.78, up 28.7%; adjusted EPS $3.00, up 15.4%, signaling strong operating leverage
  • Operating margin expanded to 15.5% from 13.7%; adjusted margin reached 16.7%
  • 2026 guidance raised: revenue $12.065B-$12.105B and adjusted EPS $11.25-$11.35
  • Cash-from-operations guidance increased to approximately $1.90B, supporting investment and shareholder returns

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Quest Diagnostics 8-K filings

Get the next DGX 8-K as it lands

Follow DGX for push alerts, or ask the research agent what this filing means.